Share-Based Compensation	9 Months Ended
Sep. 30, 2026
Share-Based Payment Arrangement [Abstract]
Share-Based Compensation	Share-Based Compensation Pursuant to the Strive, Inc. Amended and Restated 2022 Equity Incentive Plan (the "2022 Plan") and the Strive, Inc. 2026 Omnibus Equity Incentive Plan (the "2026 Plan", and together with the 2022 Plan, the "Plans"), as such Plans may be amended from time to time, the Company may, subject to the terms and limitations of the Plans, grant compensatory awards, including restricted stock ("RSAs"), stock appreciation rights, restricted stock units ("RSUs"), performance stock units ("PSUs"), incentive stock options, and non-statutory stock options. In connection with the consummation of the Semler Scientific Merger, options to purchase 0.4 million and 0.6 million shares of Class A common stock previously issued under the Semler Scientific, Inc. 2014 Stock Option and Incentive Plan and the Semler Scientific, Inc. 2024 Stock Option and Incentive Plan (collectively, the "Semler Scientific Plans"), respectively, were assumed by the Company. As of September 30, 2026, 0.8 million options remain outstanding, with a weighted average exercise price of $37.06. As of September 30, 2026, aggregate unrecognized compensation expense for outstanding option awards was $1.4 million, which is expected to be recognized over a remaining weighted-average period of 2.3 years. Incentive Stock Options Pursuant to the 2026 Plan, options to purchase shares of the Company's common stock may be granted at an exercise price not less than 100% of the fair value of the common stock subject to the option on the date the option is granted. A maximum of 5.5 million shares of common stock were authorized for issuance under the 2026 Plan. Of this amount, 5.5 million shares remain available for future awards as of September 30, 2026. Restricted Stock, Restricted Stock Units, and Performance Awards Pursuant to the Plans, RSAs and RSUs may be granted to certain employees, directors, and consultants. Substantially all RSAs and RSUs vest over periods ranging from one to five years, pro-rata over the requisite service period, with the first vesting event occurring at the first anniversary of the award's grant date, with subsequent pro-rata vesting events quarterly thereafter. The RSU grants also contain a performance condition requiring a Liquidity Event or IPO, as defined in the Plans, to occur for the vesting of the RSUs. Compensation cost is recognized using the straight-line method over the requisite service period, to the extent such performance condition is deemed probable, which occurred upon the consummation of the Asset Entities Merger. RSU awards are typically valued using the market price of the Company's Class A common stock at the grant date. Pursuant to the Plans, PSUs may also be granted to participants and are earned based on the satisfaction of predetermined performance conditions. The PSUs are eligible to be earned based on the achievement of specified levels of the Company's total shareholder return ("TSR") relative to the return of Bitcoin, as well as the Russell 3000, in each case over the defined three-year performance period. The number of PSUs that vest following the performance period ranges from 0% to 200% of the applicable target number of PSUs, based on the level of achievement of the applicable performance goals. The vesting of the PSUs is also subject to the individual's continued employment through the end of the applicable performance period, except in the event employment is terminated by the Company without "cause", the individual resigns for "good reason", or the individual dies or becomes disabled. PSU awards are typically valued based on an estimate of the Company's TSR in relation to Bitcoin as well as companies in the Russell 3000 over the relevant performance period. As of September 30, 2026, there are no shares available for future awards under the 2022 Plan. The 2026 Plan permits the grant of up to 5.9 million shares of common stock, of which 3.7 million remain available for future awards as of September 30, 2026. During the three months ended September 30, 2026, the Company did not grant RSU awards. During the three months ended September 30, 2026, the Company granted 0.7 million PSU awards with a grant date fair value of $12.7 million. Prior to this grant, no PSUs had been granted. During the period from September 12, 2025 to September 30, 2025, the Company granted 231 thousand RSU awards with a grant date fair value of $39.3 million. During the period from July 1, 2025 to September 11, 2025, the Predecessor granted 16 thousand RSU awards (which, after giving effect to the Exchange Ratio as a result of the Asset Entities Merger, equaled 1.2 million RSU awards, or 58 thousand on a split-adjusted basis) with a grant date fair value of $0.8 million. During the nine months ended September 30, 2026, the Company granted 0.9 million RSU awards with a grant date fair value of $9.5 million. During the nine months ended September 30, 2026, the Company granted 0.7 million PSU awards with a grant date fair value of $12.7 million. During the period from January 1, 2025 to September 11, 2025, the Predecessor granted 43 thousand RSU awards (which, after giving effect to the Exchange Ratio as a result of the Asset Entities Merger, equaled 3.0 million RSU awards, or 152 thousand on a split-adjusted basis) with a grant date fair value of $2.1 million. At September 30, 2026, aggregate unrecognized compensation expense for unvested equity awards was $47.8 million, which is expected to be recognized over a remaining weighted-average period of 2.2 years. At December 31, 2025, aggregate unrecognized compensation expense for unvested equity awards was $43.8 million, which is expected to be recognized over a remaining weighted-average period of 2.5 years.

Pursuant to the Strive, Inc. Amended and Restated 2022 Equity Incentive Plan (the "2022 Plan") and the Strive, Inc. 2026 Omnibus Equity Incentive Plan (the "2026 Plan", and together with the 2022 Plan, the "Plans"), as such Plans may be amended from time to time, the Company may, subject to the terms and limitations of the Plans, grant compensatory awards, including restricted stock ("RSAs"), stock appreciation rights, restricted stock units ("RSUs"), performance stock units ("PSUs"), incentive stock options, and non-statutory stock options. In connection with the consummation of the Semler Scientific Merger, options to purchase 0.4 million and 0.6 million shares of Class A common stock previously issued under the Semler Scientific, Inc. 2014 Stock Option and Incentive Plan and the Semler Scientific, Inc. 2024 Stock Option and Incentive Plan (collectively, the "Semler Scientific Plans"), respectively, were assumed by the Company. As of September 30, 2026, 0.8 million options remain outstanding, with a weighted average exercise price of $37.06. As of September 30, 2026, aggregate unrecognized compensation expense for outstanding option awards was $1.4 million, which is expected to be recognized over a remaining weighted-average period of 2.3 years.

Pursuant to the 2026 Plan, options to purchase shares of the Company's common stock may be granted at an exercise price not less than 100% of the fair value of the common stock subject to the option on the date the option is granted. A maximum of 5.5 million shares of common stock were authorized for issuance under the 2026 Plan. Of this amount, 5.5 million shares remain available for future awards as of September 30, 2026.

Pursuant to the Plans, RSAs and RSUs may be granted to certain employees, directors, and consultants. Substantially all RSAs and RSUs vest over periods ranging from one to five years, pro-rata over the requisite service period, with the first vesting event occurring at the first anniversary of the award's grant date, with subsequent pro-rata vesting events quarterly thereafter. The RSU grants also contain a performance condition requiring a Liquidity Event or IPO, as defined in the Plans, to occur for the vesting of the RSUs. Compensation cost is recognized using the straight-line method over the requisite service period, to the extent such performance condition is deemed probable, which occurred upon the consummation of the Asset Entities Merger. RSU awards are typically valued using the market price of the Company's Class A common stock at the grant date.

Pursuant to the Plans, PSUs may also be granted to participants and are earned based on the satisfaction of predetermined performance conditions. The PSUs are eligible to be earned based on the achievement of specified levels of the Company's total shareholder return ("TSR") relative to the return of Bitcoin, as well as the Russell 3000, in each case over the defined three-year performance period. The number of PSUs that vest following the performance period ranges from 0% to 200% of the applicable target number of PSUs, based on the level of achievement of the applicable performance goals. The vesting of the PSUs is also subject to the individual's continued employment through the end of the applicable performance period, except in the event employment is terminated by the Company without "cause", the individual resigns for "good reason", or the individual dies or becomes disabled. PSU awards are typically valued based on an estimate of the Company's TSR in relation to Bitcoin as well as companies in the Russell 3000 over the relevant performance period.

As of September 30, 2026, there are no shares available for future awards under the 2022 Plan. The 2026 Plan permits the grant of up to 5.9 million shares of common stock, of which 3.7 million remain available for future awards as of September 30, 2026.

During the three months ended September 30, 2026, the Company did not grant RSU awards. During the three months ended September 30, 2026, the Company granted 0.7 million PSU awards with a grant date fair value of $12.7 million. Prior to this grant, no PSUs had been granted.

During the period from July 1, 2025 to September 11, 2025, the Predecessor granted 16 thousand RSU awards (which, after giving effect to the Exchange Ratio as a result of the Asset Entities Merger, equaled 1.2 million RSU awards, or 58 thousand on a split-adjusted basis) with a grant date fair value of $0.8 million.

During the nine months ended September 30, 2026, the Company granted 0.9 million RSU awards with a grant date fair value of $9.5 million. During the nine months ended September 30, 2026, the Company granted 0.7 million PSU awards with a grant date fair value of $12.7 million.

During the period from January 1, 2025 to September 11, 2025, the Predecessor granted 43 thousand RSU awards (which, after giving effect to the Exchange Ratio as a result of the Asset Entities Merger, equaled 3.0 million RSU awards, or 152 thousand on a split-adjusted basis) with a grant date fair value of $2.1 million.